Inorganic lead activates NF-κB in primary human CD4+ T lymphocytes

Biochemical and Biophysical Research Communications

Volumn 227, Issue 2, 1996, Pages 380-385

  Pyatt, David W ^a   Zheng, Jia Hua ^a   Stillman, Wayne S ^a   Irons, Richard D ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CD4 ANTIGEN; DIMER; DNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LEAD; TRANSCRIPTION FACTOR;

ARTICLE; CONTROLLED STUDY; DNA TRANSFECTION; GENE ACTIVATION; HUMAN; HUMAN CELL; IMMUNOTOXICITY; LEAD POISONING; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN DNA BINDING; REPORTER GENE; T LYMPHOCYTE; TRANSCRIPTION REGULATION;

EID: 0030583540     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.1996.1516     Document Type: Article

References (30)

1. 1. Folks, G., and Baltimore, D. (1987) Nature 326, 711-713.
2. 2. Alcami, J., Lain de Lera, T., Folgueira, L., et al. (1995) EMBO J. 14, 1552-1560.
3. 3. Warner, G. L., and Lawrence, D. A. (1986) Eur. J. Immunol. 16, 1337-1342.
4. 4. Warner, G. L., and Lawrence, D. A. (1986) Fed. Proc. 46, 1322.
5. 5. McCabe, M. J., Dias, J. A., and Lawrence, D. A. (1991) J. Biochem. Toxicol. 6, 269-276.
6. 6. Lawrence, D. A. (1981) Infect. Immun. 31, 136-143.
7. 7. McCabe, M. J., and Lawrence, D. A. (1990) J. Immunol. 145, 671-677.
8. 8. Borella, P., and Giardino, A. (1991) Environ. Res. 55, 165-177.
9. 9. McCabe, M. J., Jr., and Lawrence, D. A. (1991) Toxicol. Appl. Pharmacol. 111, 13-23.
10. 10. Warner, G., and Lawrence, D. (1988) Int. J. Immunopharmacol. 10 No. 5, 629-637.
11. 11. Guo, T. L., Mudzinski, S. P., and Lawrence, D. A. (1996) Toxicologist 306, 59 (Abstract).
12. 12. Thanos, D., and Mamatis, T. (1995) Cell 80, 529-532.
13. 13. Cogswell, P. C., and Scheinman, R. I. (1993) J. Immunol. 150, 2794-2804.
14. 14. Hoyos, B., Ballard, D., Bohnlein, E., Siekevitz, M., and Greene, W. (1989) Science 244, 457-460.
15. 15. Osborn, L., Kunkel, S., and Nabel, G. J. (1989) Proc. Natl. Acad. Sci. USA 86, 2336-2340.
16. 16. Ostrove, J. M., Leonard, J., Weck, K. E., Rabson, A. B., and Gendelman, H. E. (1987) J. Virol. 61, 3726-3732.
17. 17. Dinter, H., Chiu, R., Imagawa, M., Karin, M., and Jones, K. A. (1987) EMBO J. 6, 4067-4071.
18. 18. Bagasra, O., Wright, S. D., Seshamma, T., Oakes, J. W., and Pomerantz, R. J. (1992) Proc. Natl. Acad. Sci. USA 89, 6285-6289.
19. 19. Thelen, M., and Wirthmueller, U. (1994) Curr. Opin. Immunol. 6, 106-112.
20. 20. Lederer, J. A., Liou, J. S., Kim, S. M., Rice, N., and Lichtman, A. H. (1996) J. Immunol. 156, 56-63.
21. 21. Pyatt, D. W., Stillman, W. S., and Irons, R. D. (1996) Int. J. Immunopharmacol., in press.
22. 22. Markovac, J., and Goldstein, G. W. (1988) Nature 334, 71-73.
23. 23. Scheinman, R. I., Beg, A. A., and Baldwin, A. S. (1993) Mol. Cell. Biol. 13, 6089-6101.
24. 24. Goldman, M., Druent, P., and Gleichmann, E. (1991) Immunol. Today 12, 223-227.
25. 25. Griem, P., and Gleichmann, E. (1995) Current Opinion in Immunology 1, 831-838.
26. 26. Prigent, P., Saoudi, A., Pannetier, C., et al. (1995) J. Clin. Invest. 961, 1481-1489.
27. 27. Kowolenko, M., McCabe, M. J., and Lawrence, D. (1992) in Clinical Immunotoxicology (Newcombe, D. S., Rose, N. R., and Bloom, J. C., Eds.), Vol. 1, pp. 401-419. Raven Press, New York.
28. 28. Edwards, F. K., and Edwards, E. K. (1982) Cutis 30, 629-620.
29. 29. Abadin, H. Tsai, S., and Segal, S. (1993) in Toxicological Profile For Lead, U.S. Department of Commerce, Springfield, VA.
30. 30. Dignam, J. D., Lebovitz, R. M., and Roeder, R. G. (1983) Nucleic Acids Res. 11, 1475-1489.